Effect of melatonin on daily LH secretion in intact and ovariectomized ewes during the breeding season.
This study was conducted to find out whether daily LH secretion in ewes may be modulated by melatonin during the breeding season, when the secretion of both hormones is raised. Patterns of plasma LH were determined in luteal-phase ewes infused intracerebroventricularly (icv.) with Ringer-Locke solution (control) and with melatonin (100 microg/100 microl/h). Response in LH secretion to melatonin was also defined in ovariectomized (OVX) ewes without and after estradiol treatment (OVX+E2). Basal LH concentrations by themselves did not differ significantly before, during and after both control and melatonin infusions in intact, luteal-phase ewes. However, single significant (P<0.05) increases in LH concentration were noted during the early dark phase in the control and 1h after start of infusion in melatonin treated ewes. In both OVX and OVX+E2 ewes, melatonin decreased significantly (P<0.01, P<0.05, respectively) mean plasma LH concentrations as compared to the levels noted before the infusions. In OVX+E2 ewes, a single significant (P<0.05) increase in LH occurred 1h after start of melatonin treatment, similarly as in luteal-phase ewes. No significant differences in the frequencies of LH pulses before, during and after melatonin infusion were found in all treatments groups. In conclusion, melatonin may exert a modulatory effect on daily LH secretion in ewes during the breeding season, stimulating the release of this gonadotropin in the presence of estradiol feedback and inhibiting it during steroid deprivation. Thus, estradiol seems to be positively linked with the action of melatonin on reproductive activity in ewes.
Misztal
Tomasz
T
Department of Endocrinology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jablonna n., Warsaw, Poland. t.misztal@ifzz.pan.pl
Romanowicz
Katarzyna
K
Barcikowski
Bernard
B
D000818:Animals; D001947:Breeding; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D007276:Injections, Intraventricular / Q000662:veterinary; D008183:Luteal Phase; D007986:Luteinizing Hormone / Q000187:drug effects* / Q000378:metabolism*; D008550:Melatonin / Q000378:metabolism / Q000494:pharmacology*; D010052:Ovariectomy / Q000662:veterinary; D012756:Sheep / Q000502:physiology*
D004958:Estradiol; D007986:Luteinizing Hormone; D008550:Melatonin